Meanwhile, Ki67 has emerged as the most significant and widely used IHC marker for making the surrogate distinction between luminal A‐like and B‐like tumours; however, the Ki67 cut‐off for doing so remains elusive [6, 7]. This evidence concerns the gene MKI67 and neoplasm.